EQIX vs ERNA · P/E 79, rev $9.22B vs P/E 0.0, rev $582.0K
Equinix Inc (EQIX) versus Eterna Therapeutics Inc (ERNA) — a side-by-side from cached financials, not a winner call.
Equinix Inc (EQIX) is a reit - specialty company listed on US.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
Latest reported EQIX revenue for 2025-12-31 was $9.22B. Net income was $1.35B. Revenue was up 5.4% from 2024-12-31 to 2025-12-31. EQIX currently screens at market cap $74.23B and trailing P/E 79.4.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
EQIX currently screens at market cap $74.23B and trailing P/E 79.4. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
Not investment advice. Open the EQIX and ERNA stock pages for the full models.
Not investment advice.